A priori molecular descriptors in QSAR: a case of HIV-1 protease inhibitors
Authors:
- 1 March 2003
- journal article
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 21 (5) , 435-448
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Comparative Quantitative Structure−Activity Relationship Studies on Anti-HIV DrugsChemical Reviews, 1999
- Occluded Molecular Surface Analysis of Ligand−Macromolecule Contacts: Application to HIV-1 Protease−Inhibitor ComplexesJournal of Medicinal Chemistry, 1999
- Aromaticity as a Quantitative Concept. 7. Aromaticity Reaffirmed as a Multidimensional CharacteristicThe Journal of Organic Chemistry, 1998
- Comparative Binding Energy Analysis of HIV-1 Protease Inhibitors: Incorporation of Solvent Effects and Validation as a Powerful Tool in Receptor-Based Drug DesignJournal of Medicinal Chemistry, 1998
- Comparison of van der Waals and semiempirical calculations of the molecular volumes of small molecules and proteinsBiopolymers, 1997
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- The Information Content of 2D and 3D Structural Descriptors Relevant to Ligand-Receptor BindingJournal of Chemical Information and Computer Sciences, 1997
- Nonpeptidal P2 Ligands for HIV Protease Inhibitors: Structure-Based Design, Synthesis, and Biological EvaluationJournal of Medicinal Chemistry, 1996
- A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active siteJournal of Medicinal Chemistry, 1995
- Studies of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitors. III. Structure-Activity Relationship of HIV-1 Protease Inhibitors Containing Cyclohexylalanylalanine Hydroxyethylene Dipeptide lsostere.Chemical and Pharmaceutical Bulletin, 1994